IL96229A - The use of an interferon-gamma polypeptide for the preparation of medicinal preparations for the treatment of primary malignant tumors of the maple in the Edri facial pathway - Google Patents
The use of an interferon-gamma polypeptide for the preparation of medicinal preparations for the treatment of primary malignant tumors of the maple in the Edri facial pathwayInfo
- Publication number
- IL96229A IL96229A IL96229A IL9622990A IL96229A IL 96229 A IL96229 A IL 96229A IL 96229 A IL96229 A IL 96229A IL 9622990 A IL9622990 A IL 9622990A IL 96229 A IL96229 A IL 96229A
- Authority
- IL
- Israel
- Prior art keywords
- gamma interferon
- treatment
- activity
- pleura
- polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR898914780A FR2654343B1 (fr) | 1989-11-10 | 1989-11-10 | Utilisation d'un polypeptide ayant l'activite de l'interferon gamma pour la preparation de compositions pharmaceutiques destinees au traitement de cancers primitifs de la plevre. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL96229A0 IL96229A0 (en) | 1991-08-16 |
| IL96229A true IL96229A (en) | 1998-04-05 |
Family
ID=9387288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL96229A IL96229A (en) | 1989-11-10 | 1990-11-02 | The use of an interferon-gamma polypeptide for the preparation of medicinal preparations for the treatment of primary malignant tumors of the maple in the Edri facial pathway |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5108743A (de) |
| EP (1) | EP0427633B1 (de) |
| JP (1) | JPH07103042B2 (de) |
| KR (1) | KR0169975B1 (de) |
| AT (1) | ATE96035T1 (de) |
| AU (1) | AU645042B2 (de) |
| CA (1) | CA2029670A1 (de) |
| DE (1) | DE69004051T2 (de) |
| DK (1) | DK0427633T3 (de) |
| FR (1) | FR2654343B1 (de) |
| HU (1) | HU206049B (de) |
| IL (1) | IL96229A (de) |
| OA (1) | OA09469A (de) |
| ZA (1) | ZA907649B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5043294B2 (ja) * | 2003-09-29 | 2012-10-10 | エー・デー・ガイストリヒ・ゾーネ・アクチェンゲゼルシャフト・フュール・ヒェーミシェ・インダストリー | 中皮腫を治療する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ217885A (en) * | 1985-10-15 | 1989-06-28 | Hoffmann La Roche | Stabilised compositions of interferon |
| EP0302862A1 (de) * | 1986-03-17 | 1989-02-15 | Schering Corporation | Behandlung von krebs mit gamma-interferon |
| ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
| EP0278715A3 (de) * | 1987-02-09 | 1989-03-08 | Schering Corporation | Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen |
-
1989
- 1989-11-10 FR FR898914780A patent/FR2654343B1/fr not_active Expired - Fee Related
-
1990
- 1990-09-25 ZA ZA907649A patent/ZA907649B/xx unknown
- 1990-10-30 US US07/605,986 patent/US5108743A/en not_active Expired - Lifetime
- 1990-11-02 IL IL96229A patent/IL96229A/en not_active IP Right Cessation
- 1990-11-08 JP JP2301245A patent/JPH07103042B2/ja not_active Expired - Lifetime
- 1990-11-08 DE DE90403174T patent/DE69004051T2/de not_active Expired - Lifetime
- 1990-11-08 EP EP90403174A patent/EP0427633B1/de not_active Expired - Lifetime
- 1990-11-08 DK DK90403174.7T patent/DK0427633T3/da active
- 1990-11-08 AT AT90403174T patent/ATE96035T1/de not_active IP Right Cessation
- 1990-11-09 AU AU66511/90A patent/AU645042B2/en not_active Ceased
- 1990-11-09 OA OA59887A patent/OA09469A/xx unknown
- 1990-11-09 KR KR1019900018127A patent/KR0169975B1/ko not_active IP Right Cessation
- 1990-11-09 CA CA002029670A patent/CA2029670A1/fr not_active Abandoned
- 1990-11-16 HU HU907180A patent/HU206049B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR0169975B1 (ko) | 1999-02-01 |
| EP0427633B1 (de) | 1993-10-20 |
| CA2029670A1 (fr) | 1991-05-11 |
| ATE96035T1 (de) | 1993-11-15 |
| JPH03188025A (ja) | 1991-08-16 |
| HUT55995A (en) | 1991-07-29 |
| DE69004051D1 (de) | 1993-11-25 |
| EP0427633A1 (de) | 1991-05-15 |
| IL96229A0 (en) | 1991-08-16 |
| KR910009280A (ko) | 1991-06-28 |
| AU645042B2 (en) | 1994-01-06 |
| FR2654343A1 (fr) | 1991-05-17 |
| DE69004051T2 (de) | 1994-03-03 |
| HU206049B (en) | 1992-08-28 |
| HU907180D0 (en) | 1991-05-28 |
| OA09469A (fr) | 1992-11-15 |
| AU6651190A (en) | 1991-05-16 |
| ZA907649B (en) | 1991-11-27 |
| DK0427633T3 (da) | 1994-01-31 |
| US5108743A (en) | 1992-04-28 |
| FR2654343B1 (fr) | 1994-08-05 |
| JPH07103042B2 (ja) | 1995-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94028670A (ru) | Иммунопотенциирующие агенты, способы лечения иммунодефицитных млекопитающих, а также вирусных инфекций и рака у млекопитающих | |
| RH et al. | Peripheral neuritis in systemic lupus erythematosus. | |
| NL8501995A (nl) | Werkwijze voor het remmen van acuut stralingssyndroom en het optreden van septiceem en daarvoor te gebruiken preparaat. | |
| JPH03501382A (ja) | 組換えコロニー刺激因子‐１の使用 | |
| Sabroe et al. | Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. | |
| EP0396903B1 (de) | Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL | |
| US5219565A (en) | Treatment of primary cancers of the pleura | |
| US5268169A (en) | Treatment method of ovarian cancer using interferon gamma | |
| IL96229A (en) | The use of an interferon-gamma polypeptide for the preparation of medicinal preparations for the treatment of primary malignant tumors of the maple in the Edri facial pathway | |
| Christophersen et al. | Interferon therapy in neoplastic disease: a preliminary report | |
| JPS6236331A (ja) | 抗感染症剤ならびに免疫賦活剤 | |
| Crockett et al. | Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis | |
| JP2002275089A (ja) | 組み換えコロニー刺激因子−１の使用 | |
| EP0931084B1 (de) | 1,3-dicarbonsäuregermaniumkomplex und dessen therapeutische verwendung | |
| Werenne et al. | Antiviral effect of bacterially produced human interferon (Hu-IFNα2) against experimental vaccinia infection in calves | |
| US5358709A (en) | Antitumoral composition based on polypeptides having human interleukin 2 activity | |
| AU632528B2 (en) | Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route | |
| JPH0331215A (ja) | 制癌療法支持剤 | |
| US6143742A (en) | Treatment for necrotizing infections | |
| JPH059131A (ja) | 抗癌剤 | |
| JPH01313433A (ja) | 抗ｈｉｖ剤 | |
| JPH0558907A (ja) | 気胸治療のための医薬組成物の製造のためのヒトインターロイキン２の活性を有するポリペプチドの利用 | |
| Alangaden et al. | In vitro activity of ertapenem against gram-negative bacilli isolated from blood stream infections in cancer patients | |
| JPH05271095A (ja) | 抗癌剤 | |
| JPH01193231A (ja) | 抗腫瘍剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HCE | Change of name and address of proprietor(s) | ||
| KB | Patent renewed | ||
| HCA | Change of name of proprietor(s) after amalgamation | ||
| KB | Patent renewed | ||
| FF | Patent granted | ||
| EXP | Patent expired |